Cite
APA Citation
Inoue, Y., Suda, T., Kitamura, H., Okamoto, M., Azuma, A., Inase, N., Kuwana, M., Makino, S., Nishioka, Y., Ogura, T., Takizawa, A., Ugai, H., Stowasser, S., Schlenker-Herceg, R., & Takeuchi, T. (2021). efficacy and safety of nintedanib in Japanese patients with progressive fibrosing interstitial lung diseases: Subgroup analysis of the randomised, double-blind, placebo-controlled, phase 3 INBUILD trial. Respiratory medicine, 187, . http://access.bl.uk/ark:/81055/vdc_100144516982.0x00002c